3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Stomach Neoplasms
81
Colorectal Neoplasms
72
Rectal Neoplasms
47
Colonic Neoplasms
25
Pancreatic Neoplasms
24
Neoplasm Metastasis
17
Carcinoma, Hepatocellular
17
Esophageal Neoplasms
11
Cholangiocarcinoma
9
Neoplasms
7
Lymphoma, Large B-Cell, Diffuse
7
Liver Neoplasms
7
Biliary Tract Neoplasms
6
Colorectal Cancer Metastatic
5
Carcinoma, Non-Small-Cell Lung
5
Recurrence
4
Lymphoma, Extranodal NK-T-Cell
4
Gallbladder Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
3
Locally Advanced Rectal Cancer
3
Gastrointestinal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Adenocarcinoma
3
Solid Tumors
2
Solid Tumor
2
Ovarian Neoplasms
2
Neurotoxicity Syndromes
2
Lymphoma
2
Lung Neoplasms
2
Locally Advanced Colon Cancer
2
Interventions
Carboplatin
15
camrelizumab
11
Capecitabine
11
130-nm albumin-bound paclitaxel
10
pembrolizumab
8
eribulin
8
Paclitaxel
8
Cyclophosphamide
8
Epirubicin
7
Gemcitabine
6
Cisplatin
6
tislelizumab
5
apatinib
5
atezolizumab
4
anlotinib
4
Taxes
4
Nivolumab
4
Docetaxel
4
Bevacizumab
4
toripalimab
3
Vinorelbine
3
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Doxorubicin
3
Albumin-Bound Paclitaxel
3
talazoparib
2
spartalizumab
2
olaparib
2
fluzoparib
2
famitinib
2
Zoledronic Acid
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Triple Negative Breast Neoplasms
×
Oxaliplatin
×
Clear all
NCT01528826
2012-02-08
NVBOX
Fudan University
Phase 2
Unknown
35 enrolled